Google Chrome
Safari
Firefox
Edge
Article / Sep 21, 2021
Design and synthesis of naphthylchalcones as novel anti-leukemia agents
Bioorganic Chemistry, September 21, 2021
Search
Article / May 20, 2022
Semi-continuous and continuous processes for enantiomeric separation
Green Chemistry, May 20, 2022
Article / Jun 20, 2022
Multivalent NHS-activated acrylates for orthogonal site-selective functionalisation of peptides at cysteine residues
Chemical Communications (Cambridge, United Kingdom), june 20, 2022
Article / Mar 09, 2022
Monofluoromethylation of complex pharmaceutical steroids using non-depleting reagents
Research & Reviews: Journal of Pharmacy and Pharmaceutical Sciences, March 9, 2022
Press Release / Jan 17, 2023
Hovione is recognized as a Top Employer 2023
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Hovione New Jersey - Office
Office
Press Release / Mar 07, 2023
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
Press Clipping / Mar 14, 2023
Hovione receives the 2023 CDMO Leadership Award in all six categories and is champion in Compatibility and Expertise
Teknoscienze, 13 March 2023
Press Release / Mar 20, 2023
Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics have entered a strategic partnership to expand the use of Ripple's Epidel® platform beyond ophthalmic applications.
Press Release / Mar 22, 2023
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
This partnership will create an opportunity for the pharmaceutical industry to develop and manufacture clinical materials and secure industrial scale production under cGMP with Hovione, using Laxxon Medical’s 3D screen printing technology.